Accelerate Diagnostics scheduled call to review 2022 second quarter results
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, August 15, 2022, at 4:30 p.m....
Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, August 15, 2022, at 4:30 p.m....
Commercialization of the Accelerate Arc system, which includes the Accelerate Arc Module and BC kit, unlocks the path to automated, rapid microbial identification (ID) for positive blood cultures across the large installed base of MALDI system users. The Accelerate Arc system can cut hours of wait time, eliminate la...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of...
/PRNewswire/ -- According to Coherent Market Insights, the global antimicrobial susceptibility testing market is estimated to be valued at US$ 3,525.75 million...
/PRNewswire/ -- According to Coherent Market Insights, the global antimicrobial susceptibility testing market is estimated to be valued at US$ 3,525.75 million...